Jul 16, 2018 - Does the $4.7 Billion Talc Verdict Spell Trouble for J&J?
Jul 13, 2018 - Amgen Inc. (AMGN) and its partner UCB announce the resubmission of the BLA to the FDA for Evenity to treat osteoporosis in postmenopausal women and in men at increased risk of fracture.
Jul 13, 2018 - ResTORbio reports Phase 2 positive data.FDA accepts Roche’s marketing application for review.AbbVie’s candidate fails in Phase 3 trial.
Jul 13, 2018 - The positive trend seen in J&J's (JNJ) pharma segment sales in the past three quarters is likely to continue in Q2
Jul 13, 2018 - Pfizer (PFE) is re-organizing its business into three new units, effective 2019. A St Louis jury orders J&J (JNJ) to pay $4.69 billion in a lawsuit related to its talc-based products.
Jul 13, 2018 - The index enjoyed a strong week of gains, boosted by expectations of a strong second quarter earnings season.
Jul 12, 2018 - Chesley Taft & Associates Llc Buys iShares Core S&P Small-Cap, Merck Inc, United Technologies Corp, Sells Philip Morris International Inc, Comcast Corp, Invesco Senior Loan, Stocks: IJR,MRK,UTX,NVDA,C,FLOT,STZ,BNDX,MTN,OKE,CSX,DVMT,, release date:Jul 12, 2018
Jul 12, 2018 - Bristol-Myers comes back swinging in colorectal cancer. Pembro not to be outshone today, attacks a different GI cancer. Asterias wants you to know that they're getting there in lung cancer.
Jul 12, 2018 - Pfizer (PFE) is re-organizing its business into three business segments, effective 2019. It is separating its consumer healthcare business into a standalone unit.
Jul 12, 2018 - The positive trend seen in J&J's (JNJ) pharma segment sales in the past three quarters is likely to continue in Q2.